You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
思創醫惠(300078.SZ):上半年淨利8934.09萬元 同比增22.46%
格隆匯 08-23 21:40

格隆匯8月23日丨思創醫惠(300078.SZ)披露2019年半年度報告,報告期內公司實現營業收入7.24億元,同比增長24.79%;歸屬於上市公司股東的淨利潤8934.09萬元,同比增長22.46%;歸屬於上市公司股東的扣除非經常性損益後的淨利潤7787.55萬元,同比增長10.96%;基本每股收益0.11元,加權平均淨資產收益率4.00%。

報告期內,公司研發費用支出為7209.56萬元,佔營業收入的9.96%,公司核心競爭力得到持續提升。

智慧醫療業務方面,公司以智能開放平台為基礎,通過打造基於人工智能的臨牀、科研、質控、管理、教學為一體的醫療信息化服務體系,高水平實現新型智慧醫院的建設目標。公司並延伸大健康上下游產業鏈,打造從家庭、社區到醫院的可及連貫的健康醫療服務生態體系,在為居民提供“全人全程、可及連貫”的醫療服務方面開啟發展新格局。

商業智能業務方面,公司以全球領先的EAS、RFID開發與應用平台為依託,憑藉良好的製造管理水平、產能規模、品質和交貨管控等方面的優勢,在新零售業務及智慧城市領域均進行了積極佈局。報告期內,公司繼續加強對滿足客户個性化需求的高附加值產品和技術的研發儲備,進一步豐富EAS標籤、RFID標籤、ESL電子變價標籤、展保類產品等應用特定場景的各類基礎標籤和特種標籤,強化與行業內合作伙伴的技術交流,並在智能化零售的部分環節取得階段性成果。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account